Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 65.90
+1.00 (1.54%)
At close: Feb 11, 2026
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 3.37 billion as of February 13, 2026. Its market cap has increased by 93.63% in one year.
Market Cap
3.37B
Enterprise Value
2.98B
Revenue
159.02M
Ranking
n/a
PE Ratio
160.78
Stock Price
65.90
Market Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 3.37B, an increase of 142.39%. That is a compound annual growth rate of 77.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 3.37B | -5.86% |
| Dec 31, 2025 | 3.58B | 116.51% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cystech Electronics | 3.44B |
| Ruentex Interior Design | 3.41B |
| Santi Renewable Energy | 3.40B |
| Sagittarius Life Science | 3.39B |
| Jtron Technology | 3.38B |
| Gmt Global | 3.36B |
| ReaLy Development & Construction | 3.34B |
| LFA Co., Ltd. | 3.33B |